Facts
as of Nov 18, 2026
Community Engagement At Fate, we believe that supporting the communities where we live is just as important as the work we do. We contribute to our local community through employee volunteer opportunities and financial support of local organizations.
It is hiring: 6 open roles, 2 of them posted in the last 30 days.
- Legal name
- FATE THERAPEUTICS INC
- Headquarters
- San Diego, United States
- Employees
- 158US Form 5500 (plan participants) · Dec 2025 · -15% in a year
- Open roles
- 6Alion job postings
- Register numbers
- EIN 651311552
As of Nov 18, 2026, Alion lists 6 open roles at Fate Therapeutics. Fate Therapeutics is headquartered in San Diego, United States. It has raised $117M in 3 funding rounds. The latest round is Venture - Series Unknown of $50M, announced in 2020. The median pay stated in its open roles is $280k, across 5 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
FATE THERAPEUTICS INC
Not checked
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring steadily, with new roles every week.
Operations is the largest family, 33 of open roles.
2Posted in 30 days33% of open roles are fresh
0%Remote roles0 of 6
1Hiring offices
Can they hire you from United States?by your location
Likely
10 open roles are in your country: you apply locally, no move needed.
United States10On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand25
Pay56
Your chance56
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 28This week
Open roles a week: 6 then, 0 now
Where the openings areshare of open roles · trend
Operations33▼
Biotech33▼
Support11▼
Finance11▲
Science & Research11▲
Degree asked
Bachelor's Degree 75%Doctoral Degree (PhD) 25%
4 postings state a degree.
Benefits named in postingsshare of open roles
Equity6100%
Retirement plans117%
Continuous learning117%
Contract type
Full-Time 6
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
What its postings pay, by level.
$280kMedian
$180k – $300kTypical rangeUSD a year
$310kHighest paying roleMedical Director, Autoimmunity
Pay by levelmiddle half of stated pay, median marked
Head+3$300k$280k – $300k
$0$88k$175k$263k$350k
People cost
Fate Therapeutics filed a median H-1B wage of $122k in 2026.
193People on payrollPERM filings, 2025Source ↗ $122kMedian H-1B wage, 20262 casesSource ↗
Median H-1B wage by role, 2026scale to $122k
Associate Scientist, In Vivo Pharmacology · 2$122k
Source: the pay stated in the company's postings, normalised to USD a year
Named in the work visa registers of United States.
2 ▼ 33%H-1B filings in 12 months
$123kMedian offered salary
6Open roles in United States
In the register as FATE THERAPEUTICS, INC, San Diego, CA (+1 more)
Other sponsors in the same field
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
San DiegoBusiest site
Source: office addresses in postings and company registers
Ranked #7 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)
Financials
Funding rounds, investors and revenue on record.
$117MTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2020$50M1 record
2016$67M2 records
Largest rounds and grants
Sources: funding announcements, grant and company registers
Money
Fate Therapeutics has $117M paid in by investors, lenders and donors.
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Apr 2020 · Venture round
$50MPaid
Equity raised
Nov 2016 · Venture round
$56.7MPaid
Equity raised
Aug 2016 · Venture round
$10.3MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Owners & entities
Fate Therapeutics operates through 2 legal entities in 1 countries.
Legal entities2 in 1 countries
FATE THERAPEUTICS INC
operator · US EIN 651311552
US
FATE THERAPEUTICS INC
operator
US
Holders and shares as each register or filing states them.
Public record
Fate Therapeutics: 3 federal court cases.
Influence
Employees' political contributions, 2026 cycle
9 contributions · their own money, not the company's; names not shown ·
fec.gov ↗$1.8k
Patents
Published US applications
1
US federal cases naming it as a party
May 2022 – Oct 2023 · 1 as defendant · 2 closed
Most common: Patent 1, 850 Securities/Commodities 1, 830 Patent Infringement (Fed. Qst.) 1
3
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
Technologies named in job postings at Fate Therapeutics over the last 12 months, by layer, with the share of postings for each.
15Technologies in use
9Postings analysed
55/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
Oct 72026
News · Fate Therapeutics stock adds two Q4 conference dates
Fate Therapeutics stock closed at USD 2.43 on October 5, 2026, while analysts set an average target of USD 5.90. Q2 revenue reached USD 2.08 million.
Oct 62026
News · Fate Therapeutics stock gained 4.74 percent on October 5
Fate Therapeutics stock gained after the company granted 62,900 options at USD 2.30 on October 1. Second-quarter revenue reached USD 2.08 million versus USD 1.94 million consensus.
Oct 12026
Blog
The post Providence Medical Foundation appeared first on Fate Therapeutics.
Oct 12026
News · markets.businessinsider.com
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bri...
Oct 12026
Blog
The post University of Southern California appeared first on Fate Therapeutics.
Oct 12026
Blog
The post UC San Diego Moores Cancer Center appeared first on Fate Therapeutics.
Sources: the outlets named on each headline, each story once